BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 19096960)

  • 41. MicroRNAs and future therapeutic applications in cancer.
    Casalini P; Iorio MV
    J BUON; 2009 Sep; 14 Suppl 1():S17-22. PubMed ID: 19785062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy.
    Mansoori B; Mohammadi A; Shirjang S; Baradaran B
    Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):1-10. PubMed ID: 26475381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miRNA: small molecules as potential novel biomarkers in cancer.
    Shah AA; Leidinger P; Blin N; Meese E
    Curr Med Chem; 2010; 17(36):4427-32. PubMed ID: 21062260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNAs in oral cancer: Biomarkers with clinical potential.
    Yete S; Saranath D
    Oral Oncol; 2020 Nov; 110():105002. PubMed ID: 32949853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. OncomiRs: the discovery and progress of microRNAs in cancers.
    Cho WC
    Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. dbDEMC: a database of differentially expressed miRNAs in human cancers.
    Yang Z; Ren F; Liu C; He S; Sun G; Gao Q; Yao L; Zhang Y; Miao R; Cao Y; Zhao Y; Zhong Y; Zhao H
    BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S5. PubMed ID: 21143814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Versatile applications of microRNA in anti-cancer drug discovery: from therapeutics to biomarkers.
    Iguchi H; Kosaka N; Ochiya T
    Curr Drug Discov Technol; 2010 Jun; 7(2):95-105. PubMed ID: 20836759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNAs, an active and versatile group in cancers.
    Liu J; Zheng M; Tang YL; Liang XH; Yang Q
    Int J Oral Sci; 2011 Oct; 3(4):165-75. PubMed ID: 22010574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
    Neelakandan K; Babu P; Nair S
    Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. microRNA Therapeutics in Cancer - An Emerging Concept.
    Shah MY; Ferrajoli A; Sood AK; Lopez-Berestein G; Calin GA
    EBioMedicine; 2016 Oct; 12():34-42. PubMed ID: 27720213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer therapy via modulation of micro RNA levels: a promising future.
    Kota SK; Balasubramanian S
    Drug Discov Today; 2010 Sep; 15(17-18):733-40. PubMed ID: 20692360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [MicroRNA in Various Aspects of Cancer Development].
    Nambara S; Mimori K
    Gan To Kagaku Ryoho; 2017 May; 44(5):362-366. PubMed ID: 28536328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNAs in osteosarcoma.
    Zhang J; Yan YG; Wang C; Zhang SJ; Yu XH; Wang WJ
    Clin Chim Acta; 2015 Apr; 444():9-17. PubMed ID: 25661090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [MicroRNA in Body Fluids - Development of the Novel Plat Form for Cancer Therapeutics and Diagnosis].
    Takahashi RU; Prieto-Vila M; Kohama I; Ochiya T
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):899-905. PubMed ID: 30026410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiRNA-based Therapeutics for Lung Cancer.
    Wu M; Wang G; Tian W; Deng Y; Xu Y
    Curr Pharm Des; 2018 Feb; 23(39):5989-5996. PubMed ID: 28714413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deconvoluting the complexity of microRNAs in autophagy to improve potential cancer therapy.
    Yao D; Jiang Y; Gao S; Shang L; Zhao Y; Huang J; Wang J; Yang S; Chen L
    Cell Prolif; 2016 Oct; 49(5):541-53. PubMed ID: 27436709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating cell-free microRNAs as clinical cancer biomarkers.
    Armand-Labit V; Pradines A
    Biomol Concepts; 2017 May; 8(2):61-81. PubMed ID: 28448269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Small players with big roles: microRNAs as targets to inhibit breast cancer progression.
    Greene SB; Herschkowitz JI; Rosen JM
    Curr Drug Targets; 2010 Sep; 11(9):1059-73. PubMed ID: 20545613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor-associated circulating microRNAs as biomarkers of cancer.
    Wang J; Zhang KY; Liu SM; Sen S
    Molecules; 2014 Feb; 19(2):1912-38. PubMed ID: 24518808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.